Symphony Financial, Ltd. Co.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1800687
HOUSTON, TX
Position in VRTX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$366,586
+$91,964 QoQ
Shares Held
738
+20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,168
of 1,735 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Symphony Financial, Ltd. Co. holds $619,760 across 3 Biotechnology names. VRTX ranks #1 (59.1% of the industry book) .
All Filings in VRTX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $366,586 | 738 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $274,622 | 615 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $227,133 | 501 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $263,182 | 672 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,047,555 | 2,353 | Shares | Sole | 2025-08-15 | |
| 2024-12-31 | $345,919 | 859 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $646,461 | 1,390 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,031,652 | 2,201 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $976,471 | 2,336 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $358,876 | 882 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $821,361 | 2,362 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,119,425 | 3,181 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $872,113 | 2,768 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $806,562 | 2,793 | Shares | Sole | 2023-01-26 | |
| 2022-06-30 | $479,043 | 1,700 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $608,060 | 2,330 | Shares | Sole | 2022-05-13 | |
| 2020-06-30 | $290,310 | 1,000 | Shares | Sole | 2020-07-08 | |
| No filing history on record for this holder in this stock. | ||||||